Veeva Systems Inc (VEEV)
233.19
-3.33
(-1.41%)
USD |
NYSE |
Nov 13, 16:00
233.28
+0.09
(+0.04%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 37.76B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 40.26% |
| Valuation | |
| PE Ratio | 62.18 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 14.89 |
| Price to Book Value | 7.283 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 55.69% |
Profile
| Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company. |
| URL | https://www.veeva.com |
| Investor Relations URL | https://ir.veeva.com/investors/investor-overview/default.aspx |
| HQ State/Province | California |
| Sector | Health Care |
| Industry | Health Care Technology |
| Equity Style | Mid Cap/Growth |
| Next Earnings Release | Dec. 06, 2024 (est.) |
| Last Earnings Release | Aug. 28, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company. |
| URL | https://www.veeva.com |
| Investor Relations URL | https://ir.veeva.com/investors/investor-overview/default.aspx |
| HQ State/Province | California |
| Sector | Health Care |
| Industry | Health Care Technology |
| Equity Style | Mid Cap/Growth |
| Next Earnings Release | Dec. 06, 2024 (est.) |
| Last Earnings Release | Aug. 28, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |